Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections

European Journal of Pediatrics

Volumn 160, Issue 8, 2001, Pages 478-482

  Georgeson, George D ^a   Szony, Barnabás J ^b   Streitman, Károly ^b   Kovács, Attila ^b   Kovács, László ^b   László, Aranka ^b  

^a Mullikin Medical Centers   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Chromium release assay; Natural immunity; Neonatal pathology; Recurrent infection; Sepsis

Indexed keywords

CHROMIUM 51;

ARTICLE; CELL ACTIVITY; CESAREAN SECTION; CONTROLLED STUDY; DELIVERY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RECURRENT INFECTION; SEPSIS; VAGINAL DELIVERY;

CYTOTOXICITY, IMMUNOLOGIC; ESCHERICHIA COLI INFECTIONS; HUMANS; IMMUNITY, NATURAL; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; KILLER CELLS, NATURAL; LISTERIA INFECTIONS; RECURRENCE; SEPSIS; STREPTOCOCCAL INFECTIONS;

EID: 0034941980     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310100773     Document Type: Article

References (49)

1. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations
2. Molecular mechanism of natural killer cell mediated cytotoxicity
3. IL-2 and IFN gamma enhanced natural cytotoxic activity: Analysis of the role of different lymphoid subsets and implications for activation routes
4. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults
5. Relationships of prostaglandin levels and natural killer (NK) cell cytotoxicity of mononuclear cells in cord blood
6. Fetal natural killer cell function is suppressed
7. Effect of lymphokine-activated killer cell fraction on the development of human hematopoietic progenitor cells
8. Antibacterial activity of human natural killer cells
9. Experimental and theoretical kinetics study of antibacterial killing mediated by human natural killer cells
10. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity
11. Morphology and cytochemistry of human large granular lymphocytes
12. Natural killer cell activity and antibody-dependent cellular cytotoxicity in newborn infants
13. Natural killer (NK) cells inhibit human umbilical cord blood erythropoiesis
14. Human newborn natural killer cells responses to activation by monoclonal antibodies. Effects of culture with herpes simplex virus
15. Natural killer cells
16. Natural killer cells: Their roles in defense against disease
17. Difference in response of NK cell activity in newborns and adults to IL-2, IL-12 and IL-15
18. In vivo and in vitro activation of NK cytotoxicity with IL-2
19. Natural killer cytotoxicity and antibody dependent cellular cytotoxicity of human immunodeficiency virus infected cells by leucocytes from human neonates and adults
20. Relationship between decreased activity of NK cells in umbilical cord blood and infection incidence in children
21. Mononuclear cell subpopulations in preterm and full-term neonates: Independent effects of gestational age, neonatal infection, maternal pre-eclampsia, maternal betamethasone therapy and mode of delivery
22. What are natural killer cells?
23. Induction of proliferation in vitro of resting human natural killer cells: Expression of surface antigens
24. Possible involvement of natural killer cells in bone marrow graft rejection
25. Parallelism between the effects of cortisone acetate on hybrid resistance and natural killing
26. Prevention of rejection of allogeneic bone marrow transplants by NK1.1 antiserum
27. Lectin dependent T-lymphocytes and natural killer cytotoxic deficiencies in human newborns
28. How killer cells kill their targets?
29. Isolation of a lytic, pore-forming protein (perforin) from cytotoxic T lymphocytes
30. Natural killer cell activity in very low birth weight infants
31. Suppression of newborn natural killer cell activity by prostaglandin E2
32. Are "natural killer" cells involved in allograft rejection?
33. Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12
34. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells
35. Influence of acute-phase proteins on the activity of natural killer cells
36. The standardization of NK cell assays for use in studies of biological response modifiers
37. Immunological defects in septic shock. Deficiency of natural killer cells and T-lymphocytes
38. In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2
39. Two different maturational stages of natural killer lymphocytes in human newborn infants
40. Subsets of human large granular lymphocytes (LGL) exhibit accessory cell functions
41. Estrogen and anti-estrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes
42. Signals for activation of natural killer-like activity
43. Development of mitogen responding T cells and natural killer cells in the human fetus
44. Systemic natural killer activity following cardiac engraftment in the rat: Lack of correlation with graft survival
45. Development of natural killer cell function in the human fetus
46. Increase of natural killer cells in rejecting kidney grafts
47. Effect of immune RNA on NK activity of infants born to mothers with cytomegalovirus infection
48. Cytotoxic lymphocytes induce both apoptosis and necrosis in target cells